Monograph Details
|
|
Gastrointestinal Tract
> Digestive and biliary disorders
|
|
ULTRASE MT18 |
| Manufacturer |
|
Axcan Pharma |
| Legal Classification |
|
Rx
|
| Pharmacological Class |
|
Pancreatic enzymes. |
| Generic Name |
|
Lipase 18000Units, amylase 58500Units, protease 58500Units; e-c minitabs in caps. |
| Also |
• ULTRASE
• ULTRASE MT12
• ULTRASE MT20
|
| Indications |
|
Replacement therapy in exocrine pancreatic insufficiency. |
| Adults and Children |
|
Do not crush or chew; may sprinkle contents on small amount of soft food (pH <5.5). Initially 1–2 caps with meals or snacks. Adjust based on control of steatorrhea. Cystic fibrosis: initially 500 lipase Units/kg per meal; reevaluate after 2–4 weeks. |
| Contraindications |
|
Acute pancreatic conditions. Pork allergy. |
| Precautions |
|
Maintain adequate hydration. Monitor for GI obstruction. Pregnancy (Cat.C). Nursing mothers. |
| Adverse Reactions |
|
Abdominal pain/cramps, diarrhea, greasy stools, flatulence; hyperuricosuria, hyperuricemia (high doses), colonic strictures (>6000 lipase Units/kg/meal). |
| How Supplied |
|
Caps—100 |
|
|
|
|
